InvestorsHub Logo
Followers 3170
Posts 208744
Boards Moderated 2
Alias Born 02/04/2004

Re: cysonic post# 22209

Friday, 01/20/2017 12:15:13 PM

Friday, January 20, 2017 12:15:13 PM

Post# of 38634
Good info cysonic...I just want to quickly point out that both IPCI and COLL are relying on their own delivery platforms and Purdue's reformulated OxyContin patents.

The fact that the appeals court already dismissed Purdue's lawsuit claims against COLL last year while simultaneously ruling all 4 of Purdue's reformulated patents invalid...is yet another reason I don't see Purdue even attempting to launch any lawsuit against IPCI...especially since the reformulated patent has already been ruled invalid by an appeals court and the reformulated patent protection expires in the next few months.

Why would Purdue even attempt to launch a lawsuit when their patent protection expires b4 IPCI's Rexista is even going to be FDA approved right!

Forgot to mention the appeals court decision ruling the 4 reformulated Purdue patents invalid in my previous post


http://www.bizjournals.com/boston/blog/bioflash/2016/02/canton-firm-to-launch-painkiller-after-oxycontin.html


Never buy or sell based on my posts! My posts are just my opinion!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPCI News